A Pilot SMART Design for Pathological Gamblers

Pathological Gambling Clinical Trial

— SMART  

Official title:

A Pilot SMART Design for Pathological Gamblers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00685724
• Other study ID #: 07-259
• Secondary ID: P50DA009241
• Status: Completed
• Phase: N/A
• Start date: January 2008
• Est. completion date: March 2011

Study information

• Verified date: April 2019
• Source: UConn Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Pathological gambling is serious problem, with significant psychological, financial, and public health consequences. Nevertheless, controlled trials examining the efficacy of therapeutic interventions for pathological gamblers are sparse, and many pathological gamblers recover on their own, or with only minimal interventions. In this initial study of a SMART design for pathological gamblers, we will offer a brief intervention to all (n = 100), and subsequently randomize individuals based upon their initial treatment response to varying intensities of additional care from none to 8 sessions of individual cognitive behavioral therapy (CBT) plus 14 weeks of Aftercare. Gambling outcomes will be assessed pre-treatment and at about weeks 10, 24, 36 and 52.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: March 2011
• Est. primary completion date: March 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age > 18 years old, DSM-IV criteria for pathological gambling

• >2 gambling episodes in past 60 days

• spent >$100 wagering in the past 60 days

• willingness to accept random assignment after the brief intervention.

Exclusion Criteria:

• Reading level below 5th grade

• uncontrolled psychiatric conditions (e.g., active suicidal intention, psychosis, bipolar disorder)

Related Conditions & MeSH terms

• Gambling
• Pathological Gambling

Intervention

Behavioral:
• Motivational Enhancement Therapy (MET)
MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
• Cognitive-Behavioral Therapy (CBT)
In CBT, clients learn to modify their thoughts as well as their behaviors by increasing awareness of the relationship between thoughts, emotions, and actions.

Locations

Country	Name	City	State
United States	University of Connecticut Health Center	Farmington	Connecticut

Sponsors (2)

Lead Sponsor	Collaborator
UConn Health	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	self and collateral indices of gambling and gambling related problems		baseline and each follow-up